跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FENTANYL CITRATE INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FENTANYL CITRATE INJECTION, USP
Authorized
STANDARD
FENTANYL CITRATE INJECTION, USP
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
67058abf7e643c92
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
67058abf7e643c92
Drug Approval Canada Name
FENTANYL CITRATE INJECTION, USP
Product Name
FENTANYL CITRATE INJECTION, USP
Status
Marketed
Status Date
2021-06-18
Original Market Date
2021-06-18
Din
02501554
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Epidural , Intramuscular , Intravenous
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N01AH01 FENTANYL
Atc Name
n 01 ah 01
Aig Number
0123302002
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
FENTANYL (FENTANYL CITRATE)
50 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
67058abf7e643c92
Type
Standard
Back to Health Canada Approvals